The damaged intestinal barrier allows more LPS into the circulation and activates the TLR4 inflammatory signal pathway in intestinal epithelial cells, which negatively impacts the intestinal epithelial immune barrier and drives NAFLD progression [47]. This evidence concerns the gene TLR4 and metabolic dysfunction-associated steatotic liver disease.